BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KESHO
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20251204T190000
DTEND;TZID=Africa/Nairobi:20251204T203000
DTSTAMP:20260526T082921
CREATED:20251208T200234Z
LAST-MODIFIED:20251223T171606Z
UID:40728-1764874800-1764880200@kesho-kenya.org
SUMMARY:Cancer-Related Thrombosis
DESCRIPTION:Cancer-Associated Thrombosis: From Primary to Secondary Prophylaxis\nPresentation by Dr Laura Kirui\nDr Laura Kirui delivered a focused clinical update on cancer-associated thrombosis (CAT)\, addressing its epidemiology\, pathophysiology and evidence-based prevention and treatment strategies across the cancer care continuum. \nThe presentation highlighted the significantly increased risk of venous thromboembolism (VTE) among cancer patients and its associated morbidity and mortality. Mechanistic insights into cancer-driven hypercoagulability including inflammation\, dysregulated fibrinolysis\, and tumor host cellular interactions were reviewed to contextualize clinical risk. \nEmphasis was placed on risk stratification\, particularly the use of validated tools such as the Khorana score\, to guide decisions on primary thromboprophylaxis. Data supporting the use of low molecular weight heparin and selected direct oral anticoagulants in high-risk populations were discussed\, alongside bleeding considerations. The session also addressed therapeutic anticoagulation\, duration of treatment\, secondary prophylaxis and management in special scenarios including thrombocytopenia\, catheter-related thrombosis and incidental VTE. \nKey takeaway: Individualized risk assessment and ongoing reassessment are central to optimizing prevention and management of cancer-associated thrombosis.
URL:https://kesho-kenya.org/event/cancer-related-thrombosis/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/12/WhatsApp-Image-2025-12-08-at-10.54.41-PM-e1765224285156.jpeg
END:VEVENT
END:VCALENDAR